Matches in Wikidata for { <http://www.wikidata.org/entity/Q90125537> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q90125537 description "artículu científicu espublizáu en setiembre de 2019" @default.
- Q90125537 description "im September 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q90125537 description "scientific article published on 04 September 2019" @default.
- Q90125537 description "wetenschappelijk artikel" @default.
- Q90125537 description "наукова стаття, опублікована 4 вересня 2019" @default.
- Q90125537 name "The first integrins β3-mediated cellular and nuclear targeting therapeutics for prostate cancer" @default.
- Q90125537 name "The first integrins β3-mediated cellular and nuclear targeting therapeutics for prostate cancer" @default.
- Q90125537 type Item @default.
- Q90125537 label "The first integrins β3-mediated cellular and nuclear targeting therapeutics for prostate cancer" @default.
- Q90125537 label "The first integrins β3-mediated cellular and nuclear targeting therapeutics for prostate cancer" @default.
- Q90125537 prefLabel "The first integrins β3-mediated cellular and nuclear targeting therapeutics for prostate cancer" @default.
- Q90125537 prefLabel "The first integrins β3-mediated cellular and nuclear targeting therapeutics for prostate cancer" @default.
- Q90125537 P1433 Q90125537-EA85FF7B-4C55-41D8-B152-665991470D9E @default.
- Q90125537 P1476 Q90125537-040DE8A5-3AAC-4D97-BF47-0838117A839A @default.
- Q90125537 P2093 Q90125537-162CA1A8-13C4-4424-AB53-984DD818061E @default.
- Q90125537 P2093 Q90125537-1E388A3F-5201-4A63-96AE-63C496481D71 @default.
- Q90125537 P2093 Q90125537-810BCD19-45E2-4F5B-ABEF-62E9053988E0 @default.
- Q90125537 P2093 Q90125537-84FACCA9-9610-406C-BD9B-D62F563BAA66 @default.
- Q90125537 P2093 Q90125537-956612BC-5F8A-43C7-8764-B17C9EFCABB4 @default.
- Q90125537 P2093 Q90125537-9BFE88FF-FBDF-4769-8811-0F2B5B2BAD17 @default.
- Q90125537 P2093 Q90125537-BFC020FC-E05B-4E1B-80DE-90B41118FBF4 @default.
- Q90125537 P2093 Q90125537-CDD589F4-FAC0-4E66-8709-779EE443A280 @default.
- Q90125537 P2093 Q90125537-E51117A6-B39D-46BA-87A1-F1128095D236 @default.
- Q90125537 P304 Q90125537-24A18004-24DD-4BEC-AA32-19A713CC4D30 @default.
- Q90125537 P31 Q90125537-0C37E147-66C6-4A7F-A8DF-2DCF5873392B @default.
- Q90125537 P356 Q90125537-C180564D-4591-42B8-B8BC-0C22EAED7298 @default.
- Q90125537 P478 Q90125537-276EDCFF-5C02-45F1-ACB3-049FF3C92460 @default.
- Q90125537 P577 Q90125537-D15DE9CC-0F5A-4715-87D7-42D43BB99AD0 @default.
- Q90125537 P698 Q90125537-4AB4D1C9-AA40-4100-A749-FB2A23AEFC14 @default.
- Q90125537 P356 J.BIOMATERIALS.2019.119471 @default.
- Q90125537 P698 31525693 @default.
- Q90125537 P1433 Q15751139 @default.
- Q90125537 P1476 "The first integrins β3-mediated cellular and nuclear targeting therapeutics for prostate cancer" @default.
- Q90125537 P2093 "Jiao Chen" @default.
- Q90125537 P2093 "Jikang Zhang" @default.
- Q90125537 P2093 "Lei Zhang" @default.
- Q90125537 P2093 "Qiangbing Lu" @default.
- Q90125537 P2093 "Qing Jiang" @default.
- Q90125537 P2093 "Tingting Gu" @default.
- Q90125537 P2093 "Xia Meng" @default.
- Q90125537 P2093 "Xinghai Ning" @default.
- Q90125537 P2093 "Xue Shan" @default.
- Q90125537 P304 "119471" @default.
- Q90125537 P31 Q13442814 @default.
- Q90125537 P356 "10.1016/J.BIOMATERIALS.2019.119471" @default.
- Q90125537 P478 "223" @default.
- Q90125537 P577 "2019-09-04T00:00:00Z" @default.
- Q90125537 P698 "31525693" @default.